Wolfgang Miesbach: An Important Topic on How Care for Bleeding Disorders Can Be Organized Across Europe at EAHAD 2026
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
”In Dublin at EAHAD2026, an important topic was not a new drug – but how care for people with bleeding disorders can be organized across Europe.
The EAHAD–EHC accreditation model for European Haemophilia Centres lead by Ana Boban and Fariba Baghaei evolving to:
- Reflect novel therapies and gene therapy within updated centre
- Define clear roles for Comprehensive Care Centres (EHCCC) and Treating Centres (EHTC) in a hub‑and‑spoke
- Introduce structured on‑site and online audits as a permanent part of the accreditation processe
A pilot audit project across several centres tested the feasibility of combining remote and on‑site assessments and showed that audits can be used as a quality‑improvement tool, not just a regulatory exercise.
For patients and families, the EHCCC/EHTC designation means a minimum guaranteed level of multidisciplinary expertise, laboratory support and 24/7 emergency access, wherever they live.”
More from EAHAD 2026 featured in Hemostasis Today.
-
Apr 12, 2026, 22:12Maciej Banach: The ‘Metastatic’ Cardiovascular Threat We Can No Longer Ignore
-
Apr 12, 2026, 21:52Umar Jawed: The Most Dangerous Anti-D Result Is Not the Highest One – It’s the One You Underestimate Early
-
Apr 12, 2026, 21:37Demosthenes Panagiotakos: Hellenic Atherosclerosis Society Calls for Papers on Innovative Strategies in Atherosclerotic Plaque Management
-
Apr 12, 2026, 21:24Heghine Khachatryan: Diagnosing PNH in Resource-Limited Settings
-
Apr 12, 2026, 21:15Katariina Öörni: Role of Cholesterol Absorption Efficiency in Atherosclerosis
-
Apr 12, 2026, 17:34Caitlin Raymond: Granulocyte Transfusions for the Overworked Fellow
-
Apr 12, 2026, 17:33Augustina Isioma Ikusemoro: ABO Typing Is Not the Same in Infants and Adults
-
Apr 12, 2026, 17:32Bastu Odoka: Same Blood Group Does Not Guarantee Compatibility
-
Apr 12, 2026, 17:31Jack Hadfield: SARS-CoV-2–Associated Lasting Mitochondrial Injury in Cardiomyocytes